Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.46 |
| ▸ | CTSK | P43235 | 5/20 | 0.42 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.41 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.41 |
| ▸ | CTSL | P07711 | 1/20 | 0.41 |
| ▸ | CTSB | P07858 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28948946 | 1.00 | LTA4H (0.46) | LTA4HCTSKSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL19817250 | 1.00 | LTA4H (0.46) | LTA4HCTSKSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL14947101 | 1.00 | LTA4H (0.46) | LTA4HCTSKSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL7794348 | 1.00 | LTA4H (0.46) | LTA4HCTSKSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL17276053 | 0.98 | LTA4H (0.44) | LTA4HCTSKSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL18050391 | 0.98 | LTA4H (0.44) | LTA4HCTSKSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL13285738 | 0.98 | LTA4H (0.44) | LTA4HCTSKSLC1A3SLC1A2SLC1A1 | |
| Hydrochloric Acid SCHEMBL16054796 | 0.96 | LTA4H (0.43) | LTA4HCTSKSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL10138774 | 0.93 | LTA4H (0.41) | LTA4HSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL19815021 | 0.93 | LTA4H (0.41) | LTA4HSLC1A3SLC1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180049433-A1 | SEMIOCHEMICAL COMPOSITIONS FOR THE PREVENTION OF HEMATOPHAGOUS DIPTERA INSECTS FROM LANDING AND BITING ANIMALS | Institut de Recherche en Semiochimie et Ethologie Appliquee (FR) | 2018-02-22 | — | — | US | claimed |
| EP-3264895-A1 | SEMIOCHEMICAL COMPOSITIONS FOR THE PREVENTION OF HEMATOPHAGOUS DIPTERA INSECTS FROM LANDING AND BITING ANIMALS | Institut de Recherche en Semiochimie et Ethologie Appliquée (FR) | 2018-01-10 | — | — | EP | claimed |
| WO-2016142775-A1 | SEMIOCHEMICAL COMPOSITIONS FOR THE PREVENTION OF HEMATOPHAGOUS DIPTERA INSECTS FROM LANDING AND BITING ANIMALS | Institut de Recherche en Semiochimie et Ethologie Appliquee (FR) | 2016-09-15 | — | — | WO | claimed |
| US-20030036489-A1 | Consumable composition comprising perfumed particles and article containing the same | THE PROCTER & GAMBLE COMPANY | 2003-02-20 | — | — | US | claimed |
| EP-1078912-B1 | Process for the preparation of methyl cyclohexylpropionate | HAARMANN & REIMER GMBH (DE) | 2003-01-08 | — | — | EP | claimed |
| WO-2002090479-A1 | PERFUMED PARTICLES AND ARTICLES CONTAINING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 2002-11-14 | — | — | WO | claimed |
| WO-2002090481-A1 | COMPOSITIONS AND ARTICLES FOR EFFECTIVE DEPOSITION OF PERFUME | THE PROCTER & GAMBLE COMPANY (US) | 2002-11-14 | — | — | WO | claimed |
| EP-1078912-A2 | Process for the preparation of methyl cyclohexylpropionate | HAARMANN & REIMER GMBH (DE) | 2001-02-28 | — | — | EP | claimed |
| EP-0573287-B1 | Heat transfer fluid corrosion inhibitors | TEXACO CHEMICAL (US) | 1995-08-23 | — | — | EP | claimed |
| EP-0573287-A1 | Heat transfer fluid corrosion inhibitors | TEXACO DEVELOPMENT CORPORATION (US) | 1993-12-08 | — | — | EP | claimed |
| US-5242621-A | Antifreezes with storage stability | TEXACO CHEMICAL CO. (US) | 1993-09-07 | — | — | US | claimed |
| JP-55018539-A | — | — | None | — | — | JP | disclosed |
| EP-4747245-A1 | PHARMACEUTICAL COMPOUNDS | Almac Discovery Limited (GB) | 2026-05-27 | — | — | EP | disclosed |
| US-12590078-B2 | — | — | 2026-03-31 | — | — | US | disclosed |
| EP-4709710-A1 | IONIZABLE CATIONIC LIPIDS FOR RNA DELIVERY | Arcturus Therapeutics, Inc. (US) | 2026-03-18 | — | — | EP | disclosed |
| US-4220599-A | HORMONES | AKZONA INCORPORATED (US) | 1980-09-02 | — | — | US | disclosed |
| JP-S5518539-A | PERFLUORO(4-METHYL-2-OXA-BI-CYCLO4.4.0DECANE) AND PREPARATION THEREOF | AGENCY OF IND SCIENCE & TECHNOL | 1980-02-08 | — | — | JP | disclosed |
| US-4147783-A | ANDROGENS, ESTERS OF TESTOSTERONE AND DERIVATIVES | AKZONA INCORPORATED (US) | 1979-04-03 | — | — | US | disclosed |
| US-4098802-A | STEROIDS | AKZONA INCORPORATED (US) | 1978-07-04 | — | — | US | disclosed |
| US-4083973-A | ANABOLIC ACTIVITY, NANDROLONE | AKZONA INCORPORATED (US) | 1978-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12590078-B2 | — | ADRM1, USP19, USP1 | LTA4H 4020/4885CTSK 2624/4885SLC1A3 2740/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.